FDA Approves Bioetica, Inc.'s HEMOSTAGENERegister Absorbable Collagen Hemostatic Sponge

Summary

The US Food and Drug Administration (FDA) has granted premarket approval for the HEMOSTAGENE Absorbable Collagen Hemostatic Sponge, developed by Bioetica, Inc. on behalf of Coletica, S. A., following a notification from the FDA's Center for Devices and Radiological Health (CDRH) on August 15, 1995.